These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Curcuminoids in neurodegenerative diseases. Kim DS; Kim JY; Han Y Recent Pat CNS Drug Discov; 2012 Dec; 7(3):184-204. PubMed ID: 22742420 [TBL] [Abstract][Full Text] [Related]
4. An overview of the pathophysiology of neurodegenerative disorders. Willner C Altern Ther Health Med; 2004; 10(4):26-34; quiz 35, 96. PubMed ID: 15285272 [No Abstract] [Full Text] [Related]
5. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Wang JY; Wen LL; Huang YN; Chen YT; Ku MC Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effect of Antioxidants in the Brain. Lee KH; Cha M; Lee BH Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998277 [TBL] [Abstract][Full Text] [Related]
7. Development of Precision Small-Molecule Proneurotrophic Therapies for Neurodegenerative Diseases. Janssens J; Lu D; Ni B; Chadwick W; Siddiqui S; Azmi A; Etienne H; Jushaj A; van Gastel J; Martin B; Maudsley S Vitam Horm; 2017; 104():263-311. PubMed ID: 28215298 [TBL] [Abstract][Full Text] [Related]
8. Conflicting effects of N-acetylcysteine on purified neurons derived from rat cortical culture. Sagara J; Bannai S; Shikano N; Makino N Neuroreport; 2010 Apr; 21(6):416-21. PubMed ID: 20838280 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of antioxidants in the management of neurodegenerative disorders: A literature review. Panahi Y; Rajaee SM; Johnston TP; Sahebkar A J Cell Biochem; 2019 Mar; 120(3):2742-2748. PubMed ID: 29219206 [TBL] [Abstract][Full Text] [Related]
10. [New antioxidants as neuroprotective agents for the treatment of ischemic brain injury and neurodegenerative diseases]. Belousova MA; Korsakova EA; Gorodetskaia EA; Kalenikova EI; Medvedev OS Eksp Klin Farmakol; 2014; 77(11):36-44. PubMed ID: 25668946 [TBL] [Abstract][Full Text] [Related]
14. Ergothioneine treatment protects neurons against N-methyl-D-aspartate excitotoxicity in an in vivo rat retinal model. Moncaster JA; Walsh DT; Gentleman SM; Jen LS; Aruoma OI Neurosci Lett; 2002 Aug; 328(1):55-9. PubMed ID: 12123858 [TBL] [Abstract][Full Text] [Related]
15. Cyclophilin D as a potential target for antioxidants in neurodegeneration: the X-ALD case. López-Erauskin J; Ferrer I; Galea E; Pujol A Biol Chem; 2013 May; 394(5):621-9. PubMed ID: 23492556 [TBL] [Abstract][Full Text] [Related]
17. Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders. Schiavone S; Trabace L Molecules; 2018 Feb; 23(2):. PubMed ID: 29438357 [TBL] [Abstract][Full Text] [Related]
18. Applications of Antioxidants in Metabolic Disorders and Degenerative Diseases: Mechanistic Approach. Abdel-Daim MM; El-Tawil OS; Bungau SG; Atanasov AG Oxid Med Cell Longev; 2019; 2019():4179676. PubMed ID: 31467632 [No Abstract] [Full Text] [Related]
19. [Idebenone (noben) -- from theory to practice]. Rachin AP; Averchenkova AA Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5):81-4. PubMed ID: 21666596 [No Abstract] [Full Text] [Related]
20. Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Jazwa A; Cuadrado A Curr Drug Targets; 2010 Dec; 11(12):1517-31. PubMed ID: 20704549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]